Lidocaine with aminoacridine oromucosal
- Drugs List
- Therapeutic Indications
- Dosage
- Contraindications
- Precautions and Warnings
- Pregnancy and Lactation
- Side Effects
- Monograph
Presentation
Oromucosal gel containing lidocaine hydrochloride and aminoacridine hydrochloride (sugar containing and sugar-free).
Drugs List
Therapeutic Indications
Uses
Abrasions and ulcers of mouth
Dosage
Adults
Apply sparingly to the affected area(s) with a clean finger tip or a cotton wool bud. Re-apply as necessary.
Each application should normally last for an hour or more although eating and/or drinking may necessitate more frequent applications.
Children
Not all available brands are licensed for childen under 7 years.
Apply sparingly to the affected area(s) with a clean finger tip or a cotton wool bud. Re-apply as necessary.
Each application should normally last for an hour or more although eating and/or drinking may necessitate more frequent applications.
Contraindications
None known
Precautions and Warnings
Children under 7 years
Breastfeeding
Glucose-galactose malabsorption syndrome
Hereditary fructose intolerance
Pregnancy
Not suitable for treatment of teething in children
Not all available brands are licensed for all age groups
Some formulations contain sucrose
If accidental contact with the eyes occurs, rinse thoroughly with water
If symptoms persist a doctor or dentist should be consulted
Keep oral gel away from the eyes
Pregnancy and Lactation
Pregnancy
Use lidocaine with aminoacridine with caution during pregnancy.
The manufacturer advises caution if lidocaine with aminoacridine is used during pregnancy. At the time of writing animal studies are insufficient and the potential risks to humans are unknown.
Lactation
Use lidocaine with aminoacridine with caution during breastfeeding.
The manufacturer advises caution if lidocaine with aminoacridine is used during breastfeeding. At the time of writing animal studies are insufficient and the potential risks to humans are unknown.
Side Effects
Hypersensitivity reactions
Overdosage
It is strongly recommended that the UK National Poisons Information Service be consulted on cases of suspected or actual overdose where there is doubt over the degree of risk or about appropriate management.
The following number will direct the caller to the relevant local centre (0844) 892 0111
Information may be obtained if you have access to ToxBase the primary clinical toxicology database of the National Poisons Information Service. This is available via password on the internet ( www.toxbase.org ) or if this is unavailable at the backup site ( www.toxbasebackup.org ).
Further Information
Last Full Review Date: August 2019
Reference Sources
Summary of Product Characteristics: Iglu Gel. Diomed Developments Ltd. Revised July 2019.
Summary of Product Characteristics: Iglu Rapid Relief Gel. Diomed Developments Ltd. Revised July 2019.
Summary of Product Characteristics: Medijel Gel. DDD Ltd. Revised August 2018.
Medscape UK | Univadis prescription drug monographs & interactions are based on FDB Multilex Content
FDB Disclaimer : FDB Multilex is intended for the use of healthcare professionals and is provided on the basis that the healthcare professionals will retain FULL and SOLE responsibility for deciding what treatment to prescribe or dispense for any particular patient or circumstance.